Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Interest & Investment Income (2014 - 2026)

Updated

Iovance Biotherapeutics (IOVA) posted Interest & Investment Income of $3.22 million for Q2 2026, down 21.6% from $4.1 million a year earlier but up 141.3% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Interest & Investment Income (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Iovance Biotherapeutics was $7.53 million, down 64.0% year-over-year; for FY2025, it came in at $10.31 million, down 49.2% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 34.3% (FY2020 to FY2025).
  • In prior years, Iovance Biotherapeutics' Interest & Investment Income was $20.27 million in FY2024 (+55.4%), $13.04 million in FY2023 (+337.0%), $2.99 million in FY2022 (+561.9%) and $451,000 in FY2021 (-80.9%).
  • Quarterly Interest & Investment Income has run from a low of $106,000 in Q1 2022 to a high of $9.58 million in Q4 2024 over five years.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last four quarters, with growth averaging 1.8% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 700.3%; the weakest was Q4 2025, with a decline of 81.8%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $1.33 million (Q1 2026), $1.74 million (Q4 2025) and $1.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 219.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 80.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 120.60 Mn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 3.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.22 Mn
Mar 31, 2026 1.33 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 1.24 Mn
Jun 30, 2025 4.10 Mn
Mar 31, 2025 3.22 Mn
Dec 31, 2024 9.58 Mn
Sep 30, 2024 4.01 Mn
Jun 30, 2024 3.36 Mn
Mar 31, 2024 3.34 Mn
Dec 31, 2023 3.12 Mn
Sep 30, 2023 3.36 Mn
Jun 30, 2023 3.08 Mn
Mar 31, 2023 3.49 Mn
Dec 31, 2022 1.72 Mn
Sep 30, 2022 777,000.00
Jun 30, 2022 385,000.00
Mar 31, 2022 106,000.00
Dec 31, 2021 135,000.00
Sep 30, 2021 120,000.00
API Access

Iovance Biotherapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IOVA&period=max&api_key=YOUR_API_KEY